2024 Partners
Lead Partner
ScaleReady
ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf. Bringing together proven tools and technologies for cell culture, cell activation, gene editing, and cell processing, ScaleReady provides leading therapeutic developers with the most simple, scalable, and versatile manufacturing platform in the industry. Our platform includes G-Rex® cell culture technology, the Lovo and Cue cell processing systems, and a wide range of GMP proteins, reagents, media, and gene editing technologies.
Expertise Partners
Miltenyi Biotec B.V. & Co. KG
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative technologies enable solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer. Miltenyi Biotec has more than 4,700 employees in 23 countries.
Biosharing Network
The market’s most experienced provider of IRRADIATED APHERESIS DERIVED FEEDER CELLS, the BioSharing Network is a partnership between eight US blood centers. The network has over two million donors and has decades of experience recruiting donors and performing apheresis procedures. Our network provides GMP (mobilized & non-mobilized) leukopacks, bone marrow, cord blood and perinatal tissue, as well as providing support services including flowcytometry, cryopreservation and prodigy-based manufacturing. With multiple donor rooms, clean rooms for manufacturing, and strong logistics teams, we are the most reliable provider in the market.
Program Partner
CTMC
CTMC – a joint venture between MD Anderson Cancer Center and Resilience – was created to accelerate the development and manufacturing of impactful cell therapies for patients with cancer. Our strategic position within the Texas Medical Center, combined with our expertise in TIL and CAR-T development, manufacturing, and regulatory, converge to enable an accelerated path to IND for cell therapies. By leveraging the strengths of MD Anderson and Resilience we start clinical trials faster and provide a clear path to robust commercialization.
Exhibition Partner
Nanotein Technologies
Nanotein Technologies is a Berkely-based, Series-A biotechnology start-up manufacturing next generation reagents for expansion and activation of immune cells for Cell Therapy applications. Our technology is a fully soluble, protein scaffold with specific functional antibodies bound with a high-affinity linkage to the protein core. This creates a highly effective protein-antibody product, for targeted and robust activation - taking advantage of receptor clustering biology for maximum impact. On the market today, we sell products for T cell and NK cell (feeder free!) activation and expansion.
We're a technical and collaborative team - small, but mighty - and would love for our reagents to help your cell therapy manufacturing process. We love to chat with potential customers, learn about your processes and help you optimize your workflows with our reagents. Send us a message or pick up some product to get started today!
Enrich Biosystems
Enrich Biosystems Inc. is a life science tool company focusing on developing and commercializing a unique microfluidics-free cell discovery and isolation technology.
Enrich’s novel cell discovery platform, TROVO, enables a streamlined workflow of co-culturing, kinetics profiling, and image guided cell capturing based on cell behavior and function. Enrich team partners with world-class research institutions to develop critical applications for its platform, such as therapeutic T-cell discovery, tumor sample processing, and patient cancer cell line generation. Its non-fluidics, dissolvable microwells, and visual enrichment enable large-scale, low-cost, and high-precision cell-based biomedical discovery; providing a needed alternative to existing microfluidics-based, limited throughput , and expensive current technologies.
Enrich’s TROVO system has successfully been utilized at leading academic and top 10 biopharma institutes to identify and isolate highly valuable tumor-reactive T cells from a heterogeneous pool of candidates. The isolated T cells from TROVO are amenable to sequencing for identification or can be expanded for utilization in animal studies.
Event Partners
Discovery Life Sciences
Discovery Life Sciences is a leading provider of highly characterized human biospecimens and cellular starting materials integrated with expert multi-omic analytical services to advance cell and gene therapy and precision medicine programs for cancer, infectious disease, and other complex conditions. Our AllCells® RUO and GMP products have supported many complex cell and gene therapy programs transition seamlessly from early discovery to process development and manufacturing, with an average 98% collection deliverability rate.
Thermo Fisher
As the world leader in serving science, Thermo Fisher Scientific is uniquely positioned to provide the quality materials, services and support needed to accelerate the pace of cell and gene therapy development. We understand the complexity of this rapidly evolving industry and have made significant investments in cGMP raw material manufacturing and drug product manufacturing capabilities to provide innovative workflow solutions. Partner with us to access the high-quality materials, services, and support you need from discovery to clinical research and commercial cell and gene manufacturing. Through our Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab services, Patheon, and Gibco brands, we offer an unmatched combination of innovative technologies, manufacturing, and distribution capabilities.
Sony Biotechnology Inc.
Sony Biotechnology Inc. is dedicated to helping researchers working across different life science disciplines to achieve the best scientific results.
By leveraging Sony's vast know-how in electronics innovation and design we offer next-generation cell analysis systems to accelerate your discoveries. Our goal is to bring a unique perspective to the flow cytometry tools required for in-depth single cell isolation, analysis and cell sorting.
With our core expertise in automation and software development we hope to enable discovery research across immunology, oncology, cell biology and microbiology.